Silent atrial fibrillation: A critical review

Journal of Atrial Fibrillation

Volumn 7, Issue 3, 2014, Pages 39-44

  Barbarossa, Alessandro ^a   Guerra, Federico ^a   Capucci, Alessandro ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Atrial fibrillation; Cardiac implantable electronic; Detection algorithms; Devices; Holter monitoring; Loop Recorder; Silent atrial fibrillation; Stroke; Thromboembolism; Tia; Transient ischemic attack

Indexed keywords

CARDIAC IMPLANTABLE ELECTRONIC DEVICE; CARDIOVASCULAR THERAPEUTIC DEVICE; CEREBROVASCULAR ACCIDENT; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DUAL CHAMBER PACEMAKER; ELECTROCARDIOGRAPHY MONITORING; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; REVIEW; RISK FACTOR; SILENT ATRIAL FIBRILLATION; STROKE PATIENT; THROMBOEMBOLISM; TRANSIENT ISCHEMIC ATTACK; UNCERTAINTY;

EID: 84914818709     PISSN: None     EISSN: 19416911     Source Type: Journal    
DOI: None     Document Type: Review

References (46)

1. Wolf P a., Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988.
2. Camm a J, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey J-Y, Ponikowski P, Rutten FH. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur. Heart J. 2010; 31: 2369-429.
3. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G, Ricci R, Favale S, Zolezzi F, Di Belardino N, Molon G, Drago F, Villani GQ, Mazzini E, Vimercati M, Grammatico A. Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J. Am. Coll. Cardiol. 2005; 46: 1913-20.
4. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH. Subclinical atrial fibrillation and the risk of stroke. N. Engl. J. Med. 2012; 366: 120-9.
5. Glotzer T V, Daoud EG, Wyse DG, Singer DE, Ezekowitz MD, Hilker C, Miller C, Qi D, Ziegler PD. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ. Arrhythm. Electrophysiol. 2009; 2: 474-80.
6. Jabaudon D, Sztajzel J, Sievert K, Landis T, Sztajzel R. Usefulness of ambulatory 7-day ECG monitoring for the detection of atrial fibrillation and flutter after acute stroke and transient ischemic attack. Stroke. 2004; 35: 1647-51.
7. Epstein AE, Vidaillet H, Greene HL, Curtis AB, Ellenbogen KA, Simmons T, Mickel M. Frequency of symptomatic atrial fibrillation in patients enrolled in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. J. Cardiovasc. Electrophysiol. 2002; 13: 667-71.
8. Granger CB, Alexander JH, McMurray JJ V, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FWA, Zhu J, Wallentin L. Apixaban versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 2011; 365: 981-92.
9. Nieuwlaat R, Capucci A, Camm a J, Olsson SB, Andresen D, Davies DW, Cobbe S, Breithardt G, Le Heuzey J-Y, Prins MH, Lévy S, Crijns HJGM. Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur. Heart J. 2005; 26: 2422-34.
10. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener H-C, Joyner CD, Wallentin L. Dabigatran versus warfarin in patients with atrial fibrillation. N. Engl. J. Med. 2009; 361: 1139-51.
11. Maund E, McKenna C, Sarowar M, Fox D, Stevenson M, Pepper C, Palmer S, Woolacott N. Dronedarone for the treatment of atrial fibrillation and atrial flutter. Health Technol. Assess. 2010; 14: 55-62.
12. Singh BN, Connolly SJ, Crijns HJGM, Roy D, Kowey PR, Capucci A, Radzik D, Aliot EM, Hohnloser SH. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N. Engl. J. Med. 2007; 357: 987-99.
13. Lowres N, Neubeck L, Redfern J, Freedman S Ben. Screening to identify unknown atrial fibrillation. A systematic review. Thromb. Haemost. 2013; 110: 213-22.
14. Potpara TS, Polovina MM, Marinkovic JM, Lip GYH. A comparison of clinical characteristics and long-term prognosis in asymptomatic and symptomatic patients with first-diagnosed atrial fibrillation: the Belgrade Atrial Fibrillation Study. Int. J. Cardiol. 2013; 168: 4744-9.
15. Glotzer T V, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook J, Paraschos A, Love J, Radoslovich G, Lee KL, Lamas G a. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003; 107: 1614-9.
16. Senatore G, Stabile G, Bertaglia E, Donnici G, De Simone A, Zoppo F, Turco P, Pascotto P, Fazzari M. Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation. J. Am. Coll. Cardiol. 2005; 45: 873-6.
17. Gillis AM, Morck M. Atrial fibrillation after DDDR pacemaker implantation. J. Cardiovasc. Electrophysiol. 2002; 13: 542-7.
18. Israel CW, Grönefeld G, Ehrlich JR, Li Y-G, Hohnloser SH. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device. J. Am. Coll. Cardiol. 2004; 43: 47-52.
19. Orlov M V, Ghali JK, Araghi-Niknam M, Sherfesee L, Sahr D, Hettrick DA. Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial. Pacing Clin. Electrophysiol. 2007; 30: 404-11.
20. Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA, Wood MA, Burke MC. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J. Cardiovasc. Electrophysiol. 2012; 23: 359-66.
21. Hanke T, Charitos EI, Stierle U, Karluss A, Kraatz E, Graf B, Hagemann A, Misfeld M, Sievers HH. Twenty-four-hour holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy: up to 12 months experience with a novel permanently implantable heart rhythm monitor device. Circulation 2009; 120: S177-84.
22. Esperer HD, Esperer C, Cohen RJ. Cardiac arrhythmias imprint specific signatures on Lorenz plots. Ann. Noninvasive Electrocardiol. 2008; 13: 44-60.
23. Hindricks G, Pokushalov E, Urban L, Taborsky M, Kuck K-H, Lebedev D, Rieger G, Pürerfellner H. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: Results of the XPECT trial. Circ. Arrhythm. Electrophysiol. 2010; 3: 141-7.
24. Guercini F, Acciarresi M, Agnelli G, Paciaroni M. Cryptogenic stroke: time to determine aetiology. J. Thromb. Haemost. 2008; 6: 549-54.
25. Liao J, Khalid Z, Scallan C, Morillo C, O'Donnell M. Noninvasive cardiac monitoring for detecting paroxysmal atrial fibrillation or flutter after acute ischemic stroke: a systematic review. Stroke. 2007; 38: 2935-40.
26. Kessler DK, Kessler KM. Is ambulatory electrocardiography useful in the evaluation of patients with recent stroke? Chest 1995; 107: 916-8.
27. Koudstaal PJ, van Gijn J, Klootwijk a. P, van der Meche FG, Kappelle LJ. Holter monitoring in patients with transient and focal ischemic attacks of the brain. Stroke 1986; 17: 192-195.
28. Douen AG, Pageau N, Medic S. Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2.6-fold in patients with acute stroke. Stroke. 2008; 39: 480-2.
29. Ritter M a, Kochhäuser S, Duning T, Reinke F, Pott C, Dechering DG, Eckardt L, Ringelstein EB. Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke. 2013; 44: 1449-52.
30. Cotter PE, Martin PJ, Ring L, Warburton E a, Belham M, Pugh PJ. Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology 2013; 80: 1546-50.
31. Rizos T, Güntner J, Jenetzky E, Marquardt L, Reichardt C, Becker R, Reinhardt R, Hepp T, Kirchhof P, Aleynichenko E, Ringleb P, Hacke W, Veltkamp R. Continuous stroke unit electrocardiographic monitoring versus 24-hour Holter electrocardiography for detection of paroxysmal atrial fibrillation after stroke. Stroke. 2012; 43: 2689-94.
32. Sanna T, Diener H-C, Passman RS, Di Lazzaro V, Bernstein R a, Morillo C a, Rymer MM, Thijs V, Rogers T, Beckers F, Lindborg K, Brachmann J. Cryptogenic stroke and underlying atrial fibrillation. N. Engl. J. Med. 2014; 370: 2478-86.
33. Gladstone DJ, Spring M, Dorian P, Panzov V, Thorpe KE, Hall J, Vaid H, O'Donnell M, Laupacis A, Côté R, Sharma M, Blakely JA, Shuaib A, Hachinski V, Coutts SB, Sahlas DJ, Teal P, Yip S, Spence JD, Buck B, Verreault S, Casaubon LK, Penn A, Selchen D, Jin A, Howse D, Mehdiratta M, Boyle K, Aviv R, Kapral MK, Mamdani M. Atrial fibrillation in patients with cryptogenic stroke. N. Engl. J. Med. 2014; 370: 2467-77.
34. Hindricks G, Piorkowski C, Tanner H, Kobza R, Gerds-Li J-H, Carbucicchio C, Kottkamp H. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112: 307-13.
35. Klemm HU, Ventura R, Rostock T, Brandstrup B, Risius T, Meinertz T, Willems S. Correlation of symptoms to ECG diagnosis following atrial fibrillation ablation. J. Cardiovasc. Electrophysiol. 2006; 17: 146-50.
36. Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Turov A, Shirokova N, Karaskov A. Use of an implantable monitor to detect arrhythmia recurrences and select patients for early repeat catheter ablation for atrial fibrillation: a pilot study. Circ. Arrhythm. Electrophysiol. 2011; 4: 823-31.
37. Manganiello S, Anselmino M, Amellone C, Pelissero E, Giuggia M, Trapani G, Giordano B, Senatore G, Gaita F. Symptomatic and asymptomatic long-term recurrences following transcatheter atrial fibrillation ablation. Pacing Clin. Electrophysiol. 2014; 37: 697-702.
38. Joshi S, Choi AD, Kamath GS, Raiszadeh F, Marrero D, Badheka A, Mittal S, Steinberg JS. Prevalence, predictors, and prognosis of atrial fibrillation early after pulmonary vein isolation: findings from 3 months of continuous automatic ECG loop recordings. J. Cardiovasc. Electrophysiol. 2009; 20: 1089-94.
39. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener H-C, Goette A, Hindricks G, Hohnloser S, Kappenberger L, Kuck K-H, Lip GYH, Olsson B, Meinertz T, Priori S, Ravens U, Steinbeck G, Svernhage E, Tijssen J, Vincent A, Breithardt G. Outcome parameters for trials in atrial fibrillation: recommendations from a consensus conference organized by the German Atrial Fibrillation Competence NETwork and the European Heart Rhythm Association. Europace 2007; 9: 1006-23.
40. Capucci A, Guerra F. Late postoperative atrial fibrillation: minor surgery complication or major cardiovascular issue? J. Cardiovasc. Med. (Hagerstown). 2011; 12: 381-2.
41. Lorenzoni G, Folino F, Soriani N, Iliceto S, Gregori D. Cost-effectiveness of early detection of atrial fibrillation via remote control of implanted devices. J. Eval. Clin. Pract. 2014; [Ahead of print]
42. Kamel H, Hegde M, Johnson DR, Gage BF, Johnston SC. Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke. Stroke. 2010; 41: 1514-20.
43. Mayer F, Stahrenberg R, Gröschel K, Mostardt S, Biermann J, Edelmann F, Liman J, Wasem J, Goehler A, Wachter R, Neumann A. Cost-effectiveness of 7-day-Holter monitoring alone or in combination with transthoracic echocardiography in patients with cerebral ischemia. Clin. Res. Cardiol. 2013; 102: 875-84.
44. Lowres N, Neubeck L, Salkeld G, Krass I, McLachlan AJ, Redfern J, Bennett AA, Briffa T, Bauman A, Martinez C, Wallenhorst C, Lau JK, Brieger DB, Sy RW, Freedman S Ben. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study. Thromb. Haemost. 2014; 111: 1167-76.
45. Shanmugam N, Boerdlein A, Proff J, Ong P, Valencia O, Maier SKG, Bauer WR, Paul V, Sack S. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population. Europace 2012; 14: 230-7.
46. Brambatti M, Connolly SJ, Gold MR, Morillo C a, Capucci A, Muto C, Lau CP, Van Gelder IC, Hohnloser SH, Carlson M, Fain E, Nakamya J, Mairesse GH, Halytska M, Deng WQ, Israel CW, Healey JS. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation 2014; 129: 2094-9.